Cyclopharm Ltd has released a press release.
SNMMI Requests USFDA to Expedite Approval For Technegas
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from Cyclopharm
- USFDA Approval Progress for Technegas and Business Update
- Cyclopharm Investor Presentation
- Technegas USA Trial Successfully Meets Primary Endpoint
- CYC 1H2020 Business Update
- USFDA Approval to File Received for Technegas
Later from Cyclopharm
- Cyclopharm Successfully Completes A$30 Million Placement
- Cyclopharm Receives $3.1M R&D Tax Incentive for FY2020
- Confirmation of Technegas USFDA Timetable
- S&P DJI Announces March 2021 Quarterly Rebalance
- Chairmans Address to Shareholders
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm